Background: Vitamin D is a group of fat-soluble corticosteroid responsible for increasing intestinal absorption of calcium, magnesium, and phosphate, and multiple other biological effects. In humans, the most important compounds in this group are vitamin D3 [also known as cholecalciferol] and vitamin D2 [ergocalciferol]. Aim of the work: The aim of this thesis is to assess Vitamin D3 [VD3] level in patients with sino-nasal polypi in comparison with normal individuals. Patients and Methods: This prospective comparative [case-control] study conducted by the Department of ENT, Al-Azhar University Hospitals in the period from March 2019 to September 2019 and included 40 individuals who were selected by inclusion and exclusion criteria, both genders, all patients had been counseled about the nature of the study and informed written consent has been obtained. Results: Serum level of VD3 in patients with chronic rhinosinusitis with sinonasal polyps [CRSwNP] and allergic fungal rhinosinusitis [AFRS] was significantly lower than that of control subjects. Vitamin D levels ranged from 8.74 to 39 ng/ml, and there was statistically significant decrease of serum vitamin D levels in patient group when compared to control group [16.20±4.29 vs 30.56±4.83 respectively]. In addition, there was significant increase of patients with deficient and insufficient vitamin D levels in patient group when compared to control group. Conclusion: VD3 may constitute an inexpensive prophylactic and cost effective option in the therapeutic armamentarium in reducing inflammation either by itself or as a synergistic agent to traditional agents in patients suffering from sino-nasal polypi. This is an open access article under the Creative Commons license [CC BY] [https://creativecommons.org/licenses/by/2.0/] Please cite this article as: Abdel-Rahman AA, El-Sobky ME, Rezk AA, Emara MS. Evaluation of vitamin D3 level in sino-nasal polypi. IJMA 2019; 1[2]; 132-137.
INTRODUCTION
Vitamin D3 [VD3] is a potent immunemodulatory steroid hormone involved in the regulation of a variety of cell types that play a role in the local immune response [1] . Vitamin D3 [VD3] status is traditionally linked with rickets in children and osteomalacia in adults. However, levels of [VD3] have been recently found to be responsible for a number of immunological, anti-inflammatory and anti-infectious roles [2] . Some studies highlighted the potential impact of impaired VD3 status with respect to so-called "nonclassical" effects of VD3. These include cardiovascular actions, an antineoplastic agent, in prevention and/or treatment of infections and in association with the immune system [3] .
Allergic fungal rhino-sinusitis [AFRS] is a distinct subtype of chronic rhino-sinusitis [CRS] that arises as a result of a localized allergic reaction to noninvasive fungal growth in areas of compromised mucus drainage [4] . Some forms of allergic fungal rhinosinusitis [AFRS], occurs more commonly in patients who are more susceptible to VD3 deficiency providing more evidence to support a role of VD3 as a key player in the immunopathology of chronic rhinosinusitis [CRS] with nasal polyps [CRSwNP] and AFRS [5] . It is important to consider that Vitamin D insufficiency is a prevalent health problem all over the world, and this may partly explain the rising incidence of AFRS and other sinus problems [6] .
AIM OF THE WORK
The aim of this thesis is to assess Vitamin D3 [VD3] level in patients with sino-nasal polypi in comparison with normal individuals.
PATIENT AND METHOD
This prospective comparative study conducted by the Department of ear, nose and throat [ENT] diseases, Al-Azhar University, in the period from March 2019 to September 2019 and included 40 of both genders, who had been counseled for the nature of the study and informed written consent.
Eligible patients were divided into three groups: Group A: included ten patients with allergic fungal rhinosinusitis according to the following criteria [Nasal polyposis; eosinophilic mucin; computed tomography [CT] scan findings consistent with chronic fungal rhinosinusitis; histological presence of fungal hyphae or positive fungal culture]. Group B: included ten patients with chronic rhinosinusitis with sinonasal polyposis diagnosed by CT and endoscopic examination plus postoperative histopathological examination of the polyps. Group C is the control group consisting of twenty healthy volunteers with no history of sinusitis and no endoscopic evidence of inflammatory sinus disease at the time of the study. Group A and group B were subjected to functional endoscopic sinus surgery [FESS] to obtain an excisional biopsy for histopathological examination.
Exclusion criteria: Patients who had received any form of immunotherapy, or vitamin supplements within 30 days before the surgery were excluded from the study. The following data has been collected: Detailed history taking; ENT examination plus through endonasal sinoscopic examination; CT paranasal sinuses and plain chest X-ray [except for controls]; CBC including blood eosinophils, renal function tests, liver function tests, and blood sugar. Measurement of serum level of vitamin D has been done by enzyme-linked immunosorbent assay [ELISA] using an ELISA kit for Human Vit D Immunoassay. All measurements were conducted in the same laboratory, by the same researcher, with the same kit. The blood samples were centrifuged for 15 minutes at 1250g. Subsequently, sera were aliquotted and frozen at −70°C until the day of assay. .847** .000 *: significant at p level < 0.01; **: significant at p level < 0.001
DISCUSSION
This study showed that serum level 0f VD3 in patient with sinonasal polyposis either CRSwNP or fungal is significantly lower than that of the control subjects [p < 0.001]. The mean vitamin D levels in patients when compared to control group [16.20±4.29 vs 30.56±4.83 ng/ml respectively]. In addition, there was significant increase of patients with deficient and insufficient vitamin D levels in patients when compared to control group. In patients group, 80.0% had deficient, while 20.0% had insufficient vitamin D levels. In control group, 5.0% had deficient, 45.0% had insufficient and 50.0% had sufficient vitamin D levels.
In accordance with Mulligan et al., they stated that both CRSwNP and AFRS patients were identified as being VD3-insufficient compared to control and CRSsNP. [22.1±3.2 ng/ml and 38.4±3.2 ng/ml, respectively] [5] . Also McCarty et al. reported that low VD3 levels were documented in patients with chronic CRSwNP, and VD3 was shown to inhibit proliferation of nasal-polyp fibroblasts that may confirm its anti-inflammatory effect [7] . Mostafa et al. [8] study also showed that serum level of VD3 in patient with CRSwNP and AFRS is significantly lower [p < 0.001] than that of patients with CRSsNP and control subjects.
On the other hand, in their studies, Apuhan et al. [9] could not prove any association between serum VD3 level and CRSwNP. Another study showed the circulating levels of 25-OH-VD3 were equivalent between patients with CRSwNP and control [10] .
In our study, 70% of the patient group have a history of allergy with significant increase of positive history of chronic disease in patients group when compared to control group. This result is in agreement with a study done by Wjst and Hypponen [11] ; they found that the prevalence of allergic rhinitis increased across quartile groups of low VD3 serum levels.
Our study showed that VD3 levels were not influenced by gender or age among the groups studied. However, in some ways it is not surprising that there are some arguments concerning the systemic 25-OH-VD3 status in patients with CRSwNP from different races. Pinto et al. [12] showed significantly lower serum VD3 levels in African Americans with CRS compared with race and sex-matched controls. But in our study no multiple races were involved as it was not available and the number of the cases were limited.
In our study there was a significant decrease of serum calcium in patients when compared to control group [8.09±0.55 vs 9.71±0.58 mg/dl respectively]. On the other side, serum phosphate showed significant decrease in patients when compared to control group [2.26±0.41 vs 2.93±0.43 respectively]. And this could be attributed to absence the effect of vitamin D in absorption of calcium and phosphate from GIT and increase phosphate excretion through the kidney mediated by parathormone hormone released in response to calcium deficiency. This result was correspondent with a study done by Mostafa et al. [8] , as there was also a significant decrease in the serum PO4 level in patient groups compared with control groups This can be explained by the following: vitamin D deficiency stimulates the parathyroid glands, leading to secondary hyperparathyroidism, which maintains serum calcium in the normal range at the expense of mobilizing calcium from the bone and increases urinary phosphate loss, resulting in a decrease in serum phosphate level.
On the contrary, no relationships were detected between levels of serum ionized calcium, phosphate, and serum vitamin D metabolites in the study conducted by Brot et al. [13] .
In our study there was significant increase of WBCs and eosinophil count in patient when compared to control group [7.41±1.99 x 10 3 , 224.20±101.85 vs 6.07±1.56 x 10 3 and 104.25±61.01 respectively]. And this may be due to presence of allergy or fungal infection in our study groups. However, there is no evidence of relationship between eosinophilia and vit D deficiency. And this coordinated with Mulligan et al. as they were unable to identify a correlation between peripheral eosinophilia and VD3 levels [5] .
In another study, Faruk et al. [14] suggests that, when using systemic VD3 in high therapeutic dose, it reduces the size of nasal polyp and facilitates the restoration of nearly normal sinonasal mucosa. Hence, normalization of VD3 level may result in clinical improvement due to restoration of its antiinflammatory role in the body.
The above studies along with our investigation highlight the fact that there are still many controversies regarding vitamin D status in CRS.
In conclusion, VD3 may constitute an inexpensive prophylactic and cost effective option in the therapeutic armamentarium in reducing inflammation either by itself or as a synergistic agent to traditional agents in patients suffering from sino-nasal polypi. However, because there is no consensus on the serum vitamin D levels t0 consider appropriate for global health, the doses to use for its supplementation, or the cutoffs for its deficiency, we are in need of large, controlled, prospective studies on VD3 supplementation to clarify whether it has a role in the pathogenesis, prevention of and treatment for AFRS, CRSwNP, and allergic conditions.
